Alternative Site Testing (AST) Physiology

Alternative Site Testing (AST) Physiology

Introduction

Alternative Site Testing (AST) means getting the blood drop for a glucose meter from the forearm or palm instead of a fingertip. It exists for comfort: these are places where a lancet prick tends to hurt less [2]. The trade-off is timing. When glucose is steady, alternate-site readings agree closely with the fingertip, but when glucose is moving fast, some sites fall behind [2].

Physiology of AST

Fingertip readings are accurate because of blood flow, not nerves. Capillary blood (the blood in the tiny vessels a lancet opens) tracks systemic, or arterial, glucose closely, and the skin sites that lag are the ones with less superficial blood flow than the fingertip [2]. Nerve endings explain a different fact entirely: how much the prick hurts.

Part of the difference is anatomy. Hairless (glabrous) skin, such as the finger and the thenar area at the base of the thumb, contains arteriovenous anastomoses, which are direct shunts between small arteries and veins; hairy skin like the forearm lacks them [5]. The glucose data split the same way. In a study of 86 adults with type 2 diabetes, palm results matched the fingertip at every time point, while forearm and thigh results drifted 60 minutes after a meal and right after exercise [4]. We didn't find a study that tested the shunts directly as the cause, so the anatomy is a plausible explanation rather than a proven one.

Limitations of AST

AST's main limit is physiological lag time: blood at a slowly perfused site takes a while to catch up with glucose changes elsewhere in the body. In a study of 17 insulin-treated adults, researchers pushed glucose up with an oral glucose drink and then down with intravenous insulin. Forearm glucose trailed the fingertip by a median of 35 minutes [3]. The gap ran both ways, with the fingertip reading higher during the rise and lower during the fall [3].

The falling direction is the safety problem. A forearm test taken while glucose drops can still look normal after fingertip blood has already gone low, which is why the authors described these as risky delays in hypoglycemia detection [3]. Meals matter too. In a LifeScan-run study of 42 adults, forearm-to-finger differences grew with the rate of glucose change and showed up mainly 60 and 90 minutes after eating [7]. Rubbing the forearm first narrowed the gap in one study, though results varied widely between people [3], and a second study found no benefit from rubbing [4]. Whether alternate sites suit your own testing routine is a decision to make with your care team.

Technology and Innovation

Getting enough blood is harder away from the fingertip. In FDA's review of the original OneTouch Verio system, cleared in February 2011, 12 of 164 lay users got no forearm result because of error messages or too little blood, compared with 2 at the palm [6]. Low-volume electrochemical strips are what make these sites workable; the Verio strips in that review need a 0.4 µL sample [6].

Regulators treat AST as a conditional feature. FDA's 2020 guidance for prescription point-of-care meters asks makers to label limits on alternative site testing unless they have studies supporting it, and to state that alternate-site results should not be used to calibrate a continuous glucose monitor [1]. The Verio labeling puts it plainly: alternate site testing should be done only during steady-state times, when glucose is not changing rapidly [6]. That restriction to steady-state conditions is the core bargain of AST, a gentler prick in exchange for a reading that can trail the fingertip while glucose is moving.